At Oxford, began testing a new vaccine against Ebola – BBC Russian

• January 6, 2015

Post

Volunteers will introduce two doses of vaccine containing different components

Scientists from Oxford University have begun testing an experimental vaccine against the deadly disease caused by the Ebola virus.

In the tests will be attended by 72 volunteers aged 18 to 50 years.

conducted on monkeys initial tests of the vaccine, developed by the company Janssen (the pharmaceutical division of the company Johnson and Johnson), showed that the drug provides complete protection against Ebola virus.

The volunteers will be the first in Oxford people who introduce the vaccine.

“We hope to immunize all participants within a month,” – said Dr. Matthew Snape of the Division of Vaccines in Oxford, entering the University Department of Pediatrics.

” The main goal – to understand how the vaccine is safe, “- he explains.

After one or two months after the first injection, the volunteers will receive an additional dose of the vaccine.

Similar tests will be held in the United States and three African countries that are not affected by Ebola.

The first dose should prepare the immune system, and the second injection – to strengthen the immune response.

Two doses contain various components, but both include protein genes from Zaire strain Ebola. Organizers stress tests that nobody can get Ebola vaccine received.

As a result of the immune response to the vaccine organism will produce antibodies and T cells, which will be studied during the year.

From a disease caused by the Ebola virus, die up to 70% of infected

The company Johnson and Johnson said he hopes to conduct more extensive testing in Africa and Europe for three months to make the vaccine available in Liberia, Guinea and Sierra Leone to mid-2015.

The company said that two million doses of the drug could be available by the end of the year.

A health crisis caused by the Ebola outbreak caused widespread Vaccine Research.

Normally, testing of a new vaccine on humans are conducted for years before it is approved for widespread use. However, Ebola outbreak in West Africa has caused a hasty attempt to find a new effective medicine to fight the virus.

In September last year in Oxford has been tested another Ebola vaccine. In Switzerland, and Russia is also developing vaccines.